William D. McClellan Jr., Director at REATA PHARMACEUTICALS INC (RETA), sold 4,000 shares at $150.01 ($600K) on 2020-11-09, disclosed to the SEC on 2020-11-10.
Open-market sale of $600k RETA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| APEN | BUY | 2017-05-30 | $13K | — | Filing → |
| APEN | BUY | 2017-05-18 | $11K | — | Filing → |